Minor
LEVEL-2 · LEVosimendan to Improve Exercise Limitation · PH-HFpEF-2
Enrollment closed, study ongoing
Tenax Therapeutics, Inc.Phase 3 NCT07288398 Registry history of NCT07288398 on ClinicalTrials.gov (opens the registry)
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Enrollment closed, study ongoing
Tenax Therapeutics, Inc.Phase 3 NCT07288398 Registry history of NCT07288398 on ClinicalTrials.gov (opens the registry)
| Phase 3 | 3 |
Heart Disease (3) · Heart Failure (3) · Hypertension (3)